Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02286440 · ClinicalTrials.gov registry record · NA

A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression

A NA study of Depression, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
179
Enrollment target
2
Study locations

NCT02286440: Completed NA study of Depression, sponsored by Mayo Clinic.

NCT02286440 is a NA study of Depression that has completed, run by Mayo Clinic. The registered enrollment target is 179 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02286440, a NA study of Depression, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
179 participants
Enrollment target
2
Study locations

Study Summary

The overall goal of this investigator-initiated trial is to evaluate the impact of platform algorithm products designed to rapidly identify pharmacokinetic (PK) and/or pharmacodynamic (PD) genomic variation on treatment outcome of depression in adolescents. This new technology may have the potential to optimize treatment selection by improving response, minimizing unfavorable adverse events / side effects and increasing treatment adherence

Conditions Studied

Depression

Interventions

  • OTHER Treatment as usual
  • OTHER AssureRx GeneSight genotyping results

Study Locations (2)

Minnesota

  • Mayo Clinic in Rochester - Rochester
  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 179 participants
Start Date 2015-02
Est. Completion 2019-02-06
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02286440

The ClinicalTrials.gov registry entry for NCT02286440 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT02286440 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02286440 about?

NCT02286440 is a clinical study titled "A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression". The overall goal of this investigator-initiated trial is to evaluate the impact of platform algorithm products designed to rapidly identify pharmacokinetic (PK) and/or pharmacodynamic (PD) genomic variation on treatment outcome of depression in adolescents. This new technology may have the potential...

What is the current status of trial NCT02286440?

This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2015-02. Estimated completion is 2019-02-06.

What conditions does trial NCT02286440 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT02286440?

The interventions under investigation include: Treatment as usual (OTHER), AssureRx GeneSight genotyping results (OTHER).

Who is sponsoring clinical trial NCT02286440?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02286440 being conducted?

This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.